Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM)

Price 1.55p on 22-11-2024 at 17:30:00
Change -0.005p -0.32%
Buy 1.58p
Sell 1.55p
Buy / Sell IMM Shares
Last Trade: Sell 17,500.00 at 1.5445p
Day's Volume: 653,703
Last Close: 1.565p
Open: 1.575p
ISIN: GB0033711010
Day's Range 1.55p - 1.575p
52wk Range: 0.83p - 2.90p
Market Capitalisation: £6m
VWAP: 1.567702p
Shares in Issue: 416m

Recent Trades History Immupharma (IMM)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 17,500 1.5445p Ordinary
15:33:51 - 22-Nov-24
Buy* 10,000 1.575p Ordinary
15:12:35 - 22-Nov-24
Sell* 50,000 1.5445p Ordinary
14:50:24 - 22-Nov-24
Buy* 89 1.58p Ordinary
13:34:44 - 22-Nov-24
Buy* 124 1.58p Ordinary
13:34:18 - 22-Nov-24
Sell* 600 1.5445p Ordinary
13:18:27 - 22-Nov-24
Sell* 250,000 1.55p Automatic Execution
12:20:04 - 22-Nov-24
Sell* 49,743 1.5535p Ordinary
12:19:54 - 22-Nov-24
Sell* 75,000 1.57p Automatic Execution
10:56:46 - 22-Nov-24
Sell* 200,000 1.60p Ordinary
08:38:36 - 22-Nov-24

Share Price History for Immupharma

Time period:
to
Date Open High Low Close Volume

Share News for Immupharma

ImmuPharma narrows losses in first half as expenses fall

9th Sep 2024 16:46

(Alliance News) - ImmuPharma PLC on Monday expressed optimism about the potential of its pipeline, after narrowing pretax loss in the first half. Read More

ImmuPharma obtains second warrant extension with Incanthera

9th Sep 2024 12:45

(Alliance News) - ImmuPharma PLC said on Monday it had extended its warrants in Incanthera PLC for the second time, valid now until March 31, 2025. Read More

UK shareholder meetings calendar - next 7 days

21st Jun 2024 15:18

Read More

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

5th Jun 2024 16:32

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Immupharma jumps amid new IP strategy for P140 technology platform

2nd Apr 2024 12:52

(Alliance News) - Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and commercial value for its P140 technology platform. Read More

FTSE 100 Latest
Value8,262.08
Change112.81

Login to your account

Forgot Password?

Not Registered